Korro Bio (KRRO) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Stablecoin Development (SDEV) has outperformed Korro Bio (KRRO) over the past year, losing 55.9% versus a loss of 78.5%. Over five years, KRRO leads with a -97.0% price change compared with -99.9% for SDEV. Korro Bio is the larger company by market cap ($154.5 million vs $143.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KRRO | SDEV |
|---|---|---|
| Share price | $10.49 | $2.78 |
| Market cap | $154.47M | $143.87M |
| 1-day change | +7.48% | -14.46% |
| YTD return | +30.96% | -90.14% |
| 1-year return | -78.49% | -55.87% |
| 5-year return | -97.05% | -99.92% |
| EPS (TTM) | $-9.88 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.89 | $99.75 |
| 52-week low | $5.20 | $0.78 |
| Distance from 52-week high | -81.23% | -97.21% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +92.56% | — |
| Average volume | 148.80K | 11.42M |
| Shares outstanding | 14.73M | 51.75M |
| Employees | 57 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SDEV has outperformed KRRO by 22.6 percentage points over the past year.
About Korro Bio
KRRO stock →Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.
Health Care · Biotechnology: Pharmaceutical Preparations · 57 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
KRRO vs SDEV FAQ
Which is bigger, Korro Bio or Stablecoin Development?
Korro Bio (KRRO) is larger, with a market capitalization of $154.47M compared with $143.87M for Stablecoin Development (SDEV).
Which stock has performed better over the past year, KRRO or SDEV?
SDEV returned -55.87% over the past 12 months, compared with -78.49% for KRRO (price return, excluding dividends). Past performance does not predict future results.
Are Korro Bio and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.